Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Blood creatinine, Blood fibrinogen, Blood glucose, Blood potassium, Blood sodium, Cerebral haemorrhage, Haemoglobin, Mean cell haemoglobin, Mean cell volume, Neutrophil count, Platelet count, White blood cell count, Computerised tomogram head, Coagulation test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Cerebral haemorrhage; This is a spontaneous report from a contactable pharmacist downloaded from a regulatory authority-WEB ES-AEMPS-816333. An 89-year-old male patient received bnt162b2 (COMIRNATY, Batch/Lot number was not reported), via an unspecified route of administration on 26Mar2021 as 0.3 mL, single for COVID-19 immunisation. Medical history included ischaemic stroke from 2013 to an unknown date, arterial hypertension, glaucoma, dyslipidaemia from an unknown date and unknown if ongoing, transurethral bladder resection from 2007 to an unknown date, fall from 15Mar2021 and joint injury from 15Mar2021 to an unknown date. Concomitant medication included acetylsalicylic acid taken for an unspecified indication, start and stop dates were not reported. The patient experienced cerebral haemorrhage on 29Mar2021. Clinical course was as follows: Patient''s background: stroke in 2013; Hypertension; Glaucoma; Dyslipidemia; Transurethral resection of bladder tumor in 2007; Fall on 15Mar2021 without head trauma. Hip contusion, so the dose of ASA is reduced from 300 to 100 mg. Complementary examinations on admission: Patient in coma, with closed eyes without verbal response to the stimuli. To the pain stimulus, no eye opening, no verbal response and with decerebrate movements in both arms. Dysphoric right pupil due to history of surgical intervention, middle left pupil with slow photomotor. Focused gaze. Absence of oculocephalic movements. Left facial asymmetry to the Marie-Foix maneuver. Bilateral extensor plantar reflex. No abnormal movements. General analysis: Hb 98 g / L, MCV and normal MCH. Leukocytes 12100 with neutrophilia 8650. Normal platelets. Normal coagulation. Glucose 160mg / dl. Creatinine normal, Fibrinogen 79.75. Na 153mEq / L, K 3.7 mEq / L. CT 29Mar2021: Cranial CT: hyperdense intraparenchymal lesion of 60x30 mm with maximum axial diameters, located in the right midsemioval center with ipsilateral capsulo-lenticular caudal extension, with peripheral hypodense area, suggestive of corresponding to hematoma in acute evolutionary phase with associated vasogenic edema. It determines a compressive effect on the adjacent structures, altering the morphology of the ipsilateral ventral lateral nucleus, with displacement of midline structures (approximately 8mm). Free base and peritroncular cisterns. Ventricular system of conserved size and asymmetric morphology in relation to what was previously described. No images of fracture in the bone structures studied. CONCLUSION: Hematoma in acute evolutionary phase located in the right semioval center with ipsilateral capsulo-lenticular extension, which determines a compressive effect on the ipsilateral ventral lateral nucleus and displacement of midline structures (approximately 8mm). To assess probable hypertensive origin. Exitus 01Apr2021: Torpid evolution in the first 24 hours, remaining in a comatose state, without responding to stimuli, decerebrate movement to the painful stimulus, absence of oculocephalic reflex, weak corneal and middle pupil reflex with little photoreactivity. Given neurological deterioration without being a candidate for aggressive measures due to age, multiple pathologies and torpid evolution in less than 24 hours with signs of possible uncal herniation, together with the family they decided to prioritize comfort measures. The outcome of the events was fatal. The patient died on 01Apr2021. An autopsy was performed that revealed decerebration. No follow-up attempts are possible, information on batch numbers cannot be obtained.; Reported Cause(s) of Death: Cerebral haemorrhage; Autopsy-determined Cause(s) of Death: Decerebration
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166